• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1012464-28
Device Problems Improper or Incorrect Procedure or Method (2017); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Stenosis (2263)
Event Date 06/28/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).The absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the u.S.The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.The two absorb devices will be filed under separate medwatch manufacturer report reference numbers.
 
Event Description
It was reported that the patient was stented in 2009 in another hospital with non-abbott stents unknown type and sizes, then was re-stented on (b)(6) 2013 in the right coronary artery (rca) with 3 absorb stents for treatment of restenosis (3.5 x 28 distal , 3.5 x 28 mid and a 3.5 x 18 proximally).Prior to the initial procedure the patient's clinical presentation was severe angina.The patient presented to the cath lab with stable angina on (b)(6) 2018 and it was discovered that the rca was re-stenosed.Optical coherence tomography confirmed that all the absorb stents were all fully resorbed and found a tight fibrous plaque along the rca.An nc trek was used for pre-dilatation, then a cutting balloon and a 3.75 nc trek and finally a 4.0 cutting balloon were used to prepare the rca before stenting with a 3.5 x 38 xpedition distal and 3.5 x 28 xpedition proximally with great results.It was confirmed that patient was on dual antiplatelet therapy at last visit with doctor in 2016.No issues occurred and patient was stable.No additional information was provided.
 
Manufacturer Narrative
(b)(4).Correction: lot number unknown.There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record and complaint history of the reported device could not be conducted because the lot numbers were not provided.The reported patient effects of angina and restenosis, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use (ifu) are known adverse events associated with the use of a coronary scaffold in native coronary arteries.It should be noted that the ifu states: the absorb bvs is a temporary scaffold indicated for improving coronary luminal diameter that will eventually resorb and potentially facilitate normalization of vessel function in patients with ischemic heart disease due to de novo native coronary artery lesions.It is unknown if the ifu deviation contributed to the reported difficulty.Based on the case information, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key7700499
MDR Text Key114403404
Report Number2024168-2018-05586
Device Sequence Number1
Product Code PNY
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date 08/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number1012464-28
Device Lot Number3070661
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/10/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age74 YR
Patient Weight79
-
-